UNITED STATES NEWS

US rivalry with China expands to biotech. Lawmakers see a failure to compete and want to act

Feb 18, 2024, 10:07 PM

WASHINGTON (AP) — U.S. lawmakers are raising alarms about what they see as America’s failure to compete with China in biotechnology, warning of the risks to U.S. national security and commercial interests. But as the two countries’ rivalry expands into the biotech industry, some say that shutting out Chinese companies would only hurt the U.S.

Biotechnology promises to revolutionize everyday life, with scientists and researchers using it to make rapid advances in medical treatment, genetic engineering in agriculture and novel biomaterials. Because of its potential, it has caught the attention of both the Chinese and U.S. governments.

Bills have been introduced in the House and Senate to bar “foreign adversary biotech companies of concern” from doing business with federally funded medical providers. The bills name four Chinese-owned companies.

The Chinese Embassy said those behind the bills have an “ideological bias” and seek to suppress Chinese companies “under false pretexts.” It demanded that Chinese companies be given “open, just, and non-discriminatory treatment.”

The debate over biotechnology is taking place as the Biden administration tries to stabilize the volatile U.S.-China relationship, which has been battered by a range of issues, including a trade war, the COVID-19 pandemic, cybersecurity and militarization in the South China Sea.

Critics of the legislation warn that restrictions on Chinese companies would impede advances that could bring a greater good.

“In biotech, one cannot maintain competitiveness by walling off others,” said Abigail Coplin, an assistant professor at Vassar College who specializes in China’s biotech industry. She said she was worried that U.S. policymakers would get too obsessed with the technology’s military applications at the cost of hindering efforts to cure disease and feed the world’s population.

In a letter to senators sponsoring the bill, Rachel King, chief executive officer of the trade association Biotechnology Innovation Organization, said the legislation would “do untold damage to the drug development supply chain both for treatments currently approved and on market as well as for development pipelines decades in the making.”

But supporters say the legislation is crucial to protecting U.S. interests.

The National Security Commission on Emerging Biotechnology, a group created by the U.S. Senate to review the industry, said the bill would help secure the data of the federal government and of American citizens and it would discourage unfair competition from Chinese companies.

The commission warned that advancement in biotechnology can result not only in economic benefits but also rapid changes in military capabilities and tactics.

Much is at stake, said Rep. Mike Gallagher, chair of the House Select Committee on the Chinese Communist Party. Gallagher, a Wisconsin Republican, introduced the House version of the bill and last week led a congressional delegation to Boston to meet with biotech executives.

“It’s not just a supply chain battle or a national security battle or an economic security battle; I would submit it’s a moral and ethical battle,” Gallagher said. ”Just as the sector advances at a really astronomic pace, the country who wins the race will set the ethical standards around how these technologies are used.”

He argues that the U.S. must “set the rules of the road” and if not, “we’re going to live in a less free, less moral world as a result.”

Both the United States and China, the world’s two largest economies, have identified biotech as a critical national interest.

The Biden administration has put forward a “whole-of-government approach” to advance biotechnology and biomanufacturing that is important for health, climate change, energy, food security, agriculture and supply chain resilience. A stated goal is to maintain U.S. technological leadership and economic competitiveness.

The Chinese government has plans to develop a “national strategic technology force” in biotech, which would be tasked with making breakthroughs and helping China achieve “technological independence,” primarily from the U.S.

“Both the Chinese government and the Americans have identified biotech as an area important for investment, a sector that presents an opportunity to grow their economy,” said Tom Bollyky, the Bloomberg chair in global health at the Council on Foreign Relations. He said any restrictive U.S. measures should be tailored to address military concerns and concerns about genomic data security.

“Naturally there’s going to be competition, but what’s challenging in biotech is that we are talking about human health,” Bollyky said.

Ray Yip, who founded the U.S. Centers for Disease Control and Prevention office in China, also worries that the rivalry will slow medical advancements.

The benefit of coming up with better diagnostics and therapy is beyond any individual country, Yip said, “and will not overshadow the capacity or prestige of the other country.”

What concerns Anna Puglisi, a senior fellow at Georgetown University’s Center for Security and Emerging Technology, is Beijing’s lack of transparency and its unfair market practices. “Competition is one thing. Unfair competition is another thing,” she said.

Puglisi described BGI, a major Chinese biotech company identified in both the House and Senate bills, as “a national champion” that is subsidized and given favored treatment by the state in a system that “blurs private and public as well as civilian and military.”

“This system creates market distortions and undermines the global norms of science by using researchers and academic and commercial entities to further the goals of the state,” Puglisi said.

BGI, which has stressed its private ownership, offers genetic testing kits and a popular prenatal screening test to detect Down syndrome and other conditions. U.S. lawmakers say they are concerned such data could end up in the hands of the Chinese government.

The Defense Department has listed BGI as a Chinese military company, and the Commerce Department has blacklisted it on human rights grounds, citing a risk that BGI technology might have contributed to surveillance. BGI has rejected the allegations.

In raising its concerns about BGI, the National Security Commission on Emerging Biotechnology says the company is required to share data with the Chinese government, has partnered with the Chinese military, and has received considerable Chinese state funding and support.

State subsidies have allowed BGI to offer genomic sequencing services at a highly competitive price that is attractive to U.S. researchers, according to the commission. The genomic data, once in the hands of the Chinese government, “represents a strategic asset that has privacy, security, economic, and ethical implications,” it said.

BGI could not immediately be reached for comment.

Also named in the bills is WuXi AppTec, a Chinese pharmaceutical and medical device company. The legislation states that the company presents a national security threat because of its ties to the Chinese military and its involvement in a Chinese plan to develop technologies for both civilian and military use.

WuXi AppTec said in a statement that it abides by the laws in the countries where it operates and does not pose a security risk to any country. “In fact, we serve as a valued contributor to the global pharmaceutical and life sciences industries,” the company said in a statement.

___

Associated Press journalist Dake Kang in Beijing contributed to this report.

United States News

Work continues on the roof of Gaido's restaurant in preparation for opening for diners for the firs...

Associated Press

In beachy Galveston, locals buckle down without power after Beryl’s blow during peak tourist season

GALVESTON, Texas (AP) — Vacuums sucked the water out of the seaside inn run by Nick Gaido’s family in Galveston since 1911 as power was still spotty nearly one week after a resurgent Hurricane Beryl swept into Texas. Blue tarp covered much of the torn off roof. Gaido scheduled cleanup shifts for the hotel and […]

12 minutes ago

FILE - Balloons are hoisted to the ceiling in the Forum ahead of the 2024 Republican National Conve...

Associated Press

When does a presumptive nominee become a nominee? Here’s how Donald Trump will make it official

WASHINGTON (AP) — Monday 12:01 AM Nearly 2,500 delegates are gathering in Milwaukee this week for a roll call vote to select a the Republican presidential nominee, formally ending the presidential primary. It will be a moment lacking in suspense: Former President Donald Trump has already been the presumptive nominee for months, having clinched a […]

1 hour ago

Members of the Coalition to March on the RNC speak during a news conference ahead of the 2024 Repub...

Associated Press

GOP convention protests are on despite shooting at Trump rally

MILWAUKEE (AP) — Activists gathering in Milwaukee for the start of the Republican National Convention say the assassination attempt on former President Donald Trump won’t affect their long-standing plans to demonstrate outside the convention site this week. A diverse range of organizations and activists is expected outside the downtown Fiserv Forum. The largest expected demonstration […]

1 hour ago

FILE - Actor Clint Eastwood speaks to an empty chair while addressing delegates during the Republic...

Associated Press

Floor fights, boos and a too-long kiss. How the dramatic and the bizarre define convention history

WASHINGTON (AP) — In 1948, the Republican and Democratic parties did something unthinkable in today’s climate of ferocious political animosity: They not only held their national conventions in the same city, but shared some of the props. Both gathered in Philadelphia, largely because its Municipal Auditorium had already been fitted with the wiring needed for […]

1 hour ago

FILE - Republican presidential candidate former President Donald Trump speaks at a campaign rally, ...

Associated Press

The RNC’s first day will still focus on the economy. Here’s what to know about Trump’s plans

WASHINGTON (AP) — Donald Trump goes into the Republican National Convention with bold promises about the U.S. economy, but he has sketched out notably few details about how his plans would actually work. The convention’s first day is still expected to focus on the economy even after Saturday’s shooting at a Trump rally in Pennsylvania […]

1 hour ago

FILE - Wayne LaPierre arrives at court, Jan. 24, 2024, in New York. The second phase of the civil t...

Associated Press

Second phase of NRA civil trial over nonprofit’s spending set to open in NYC

NEW YORK (AP) — The second phase of the civil trial against the National Rifle Association and its top executives is set to begin Monday in Manhattan, with New York Attorney General Letitia James seeking an independent monitor to oversee the powerful gun rights group. The Democrat also is seeking to ban Wayne LaPierre, the […]

1 hour ago

Sponsored Articles

...

Condor Airlines

Condor Airlines can get you smoothly from Phoenix to Frankfurt on new A330-900neo airplane

Adventure Awaits! And there's no better way to experience the vacation of your dreams than traveling with Condor Airlines.

...

COLLINS COMFORT MASTERS

Here are 5 things Arizona residents need to know about their HVAC system

It's warming back up in the Valley, which means it's time to think about your air conditioning system's preparedness for summer.

...

Collins Comfort Masters

Here’s 1 way to ensure your family is drinking safe water

Water is maybe one of the most important resources in our lives, and especially if you have kids, you want them to have access to safe water.

US rivalry with China expands to biotech. Lawmakers see a failure to compete and want to act